Streetbeat News

Products Services

CSTL

Castle Biosciences announced plans to present new data at the 20th European Association of Dermato-Oncology Congress. This event could highlight the company's advancements in dermatology and oncology, potentially impacting its reputation and investor interest.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 8:31 pm

SNSE

Sensei Biotherapeutics' stock price increased following the announcement of a peer-reviewed research paper published in Nature Communications. The paper details the mechanism of action of SNS-101, which selectively targets the active form of VISTA within the tumor microenvironment.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 8:15 pm

IVVD

Invivyd projects its FY24 initial net product revenue for PEMGARDA to be between $150M and $200M.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 8:05 pm

GLPG

Galapagos is set to present clinical and translational data at the EBMT Congress 2024, including two oral presentations and one poster on preliminary data from Phase 1/2 CD19 CAR-T studies in non-Hodgkin lymphoma and chronic lymphocytic leukemia/Richter transformation.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 8:03 pm

IVVD

Invivyd's PEMGARD is now commercially available in the U.S. for pre-exposure prophylaxis of COVID-19 in certain adults and adolescents with moderate-to-severe immune compromise. This marks a significant step in providing additional protection against COVID-19 for individuals with compromised immune systems.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 8:03 pm

LSCC

Lattice Semiconductor has expanded its partnership with NewTec to enhance functional safety solutions for Automotive and Industrial applications. This collaboration aims to provide customers with flexible, scalable, and easy-to-implement safety solutions, catering to the growing demand in safety-critical sectors.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 8:02 pm

CYN

Cyngn has received a notice of allowance for its U.S. patent application 17/817,946, which is focused on 'System and Methods of Adaptive Object-Based Decision Making for Autonomous Driving'. This development marks a significant milestone for Cyngn in the autonomous driving technology sector.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 7:58 pm

F

Ford announced a delay in the launch of its three-row electric vehicles to 2027, alongside an expansion of its hybrid electric vehicle offerings. This news has contributed to a decrease in Ford's stock price. Additionally, broader market stocks are experiencing a downturn due to uncertainty regarding interest rate cuts.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 7:53 pm

NUWE

Nuwellis has filed a U.S. patent application (#20240108533) for a venous blood flow stimulator designed for extracorporeal therapy. This development could enhance the company's product offerings in the medical device sector, potentially leading to advancements in treatment options and patient care.

Portfolio Pulse from Charles Gross

April 04, 2024 | 7:53 pm

META

Meta Platforms, Inc. (NASDAQ:META) shares reached a new all-time high of $530.00 after Jefferies maintained a Buy rating and raised its price target from $550 to $585. The company clarified it did not share private messages with Netflix, allowing users to message friends about Netflix content directly. Meta is expected to announce Q1 financial results with earnings of $4.28 per share and revenue of $36.051 billion. The stock has grown 23.73% over the past 5 years with a beta of 1.0, indicating high volatility. Its forward P/E ratio is 25.25, above the S&P 500 average.

Portfolio Pulse from Erica Kollmann

April 04, 2024 | 7:18 pm